 |
etanercept |
|---|---|
| Trade Name | Enbrel |
| Orphan Indication | Reduction in signs and symptoms of moderately to severely active polyarticular-course juvenile rheumatoid arthritis in patients who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs |
| USA Market Approval | USA |
| USA Designation Date | 1998-10-27 00:00:00 |
| Sponsor | Immunex Corporation;One Amgen Center Drive;Thousand Oaks, California, 91320 |
